Chronos Therapeutics Chronos therapeutics, utilises high content phenotypic screens for the the discovery of new chemical entities for the treatment of neurological disorders. We currently have high throughput screens for Alzhiemer's, Huntingtons, Parkinson's Diseases and ALS.  Additionally our screening technology can be easily adapted to any new target of interest.  Coupled to this Chronos has multiple compound libaries for identification of new leads and for repositioning of known drugs.